Search results
Fed Rate Cuts Remain Elusive. Why Markets Can’t Count on Inflation Data for Insight and 5 Other...
Barrons.com· 16 hours agoFed officials are also struggling to get a clear idea of what’s happening. There will be plenty of ...
Earnings call: Invivyd optimistic about PEMGARDA's market potential By Investing.com
Investing.com· 7 hours agoThe company announced the emergency use authorization (EUA) of PEMGARDA for the prevention of COVID-...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials
Investing.com· 22 hours agoVaxart, Inc. (NASDAQ: NASDAQ: VXRT ), a biotechnology company specializing in the development of...
Cessna: A&M should have been seeded higher, but it's where you finish that matters
The Bryan-College Station Eagle· 3 hours agoThe Texas A&M softball team getting seeded 16th for the NCAA Division I softball tournament is like...
Earnings call: Vaxart posts progress in vaccine trials, Q1 financials By Investing.com
Investing.com· 4 hours agoVaxart, Inc. (NASDAQ: NASDAQ:VXRT), a biotechnology company specializing in the development of oral...
Looking back at former Trump fixer on the stand in hush money trial: Who is Michael Cohen?
USA TODAY via Yahoo News· 8 hours agoHe started his sentence in May 2019, but was sent home early for house arrest due to the COVID-19 pandemic. Where did Michael Cohen go to law school? Michael ...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 5 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
AstraZeneca withdraws Covid-19 vaccine, citing low demand | CNN Business
CNN.com· 6 days agoThe vaccine — called Vaxzevria and developed in partnership with the University of Oxford — has been...
Experts review the best hair growth oils for men and women
AOL· 4 days agoSignificant hair loss can absolutely impact how you feel about yourself, and regrowing hair after a...
Earnings call: DiaMedica Therapeutics discusses Q1 progress and challenges By Investing.com
Investing.com· 13 hours agoThe company is focused on ramping up site activation and participant enrollment for its ReMEDy2...